PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Endocrinology and Metabolism10.3803/enm.2021.11702021365917-927Review and Update of the Risk Factors and Prevention of Antiresorptive-Related Osteonecrosis of the JawHa Young Kimhttp://e-enm.org/upload/pdf/enm-2021-1170.pdf, http://e-enm.org/journal/view.php?doi=10.3803/EnM.2021.1170, http://e-enm.org/upload/pdf/enm-2021-1170.pdf
Japanese Dental Science Review10.1016/j.jdsr.2018.11.001201955158-64Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)Akira Baba, Hiroya Ojiri, Tazuko K. Goto, Koshi Ikeda, Hideomi Yamauchi, Nobuhiro Ogino, Takuji Mogamihttps://api.elsevier.com/content/article/PII:S1882761618300929?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1882761618300929?httpAccept=text/plain
Heliyon10.1016/j.heliyon.2020.e03795202064e03795Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic reviewCamilla Ottesen, Morten Schiodt, Klaus Gotfredsenhttps://api.elsevier.com/content/article/PII:S240584402030640X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S240584402030640X?httpAccept=text/plain
Reactions Weekly10.1007/s40278-014-5811-5201415311178-178Zoledronic acidhttp://link.springer.com/content/pdf/10.1007/s40278-014-5811-5.pdf, http://link.springer.com/article/10.1007/s40278-014-5811-5/fulltext.html, http://link.springer.com/content/pdf/10.1007/s40278-014-5811-5
Evidence-Based Dentistry10.1038/sj.ebd.6401149201617114-15Adjusted protocol for dental extractions in oncology patients taking anti-resorptive drugs may reduce occurrence of medication-related osteonecrosis of the jawCarolina Borges, Silvia Spivakovskyhttp://www.nature.com/articles/6401149.pdf, http://www.nature.com/articles/6401149, http://www.nature.com/articles/6401149.pdf
British Dental Journal10.1038/sj.bdj.2011.74420112115217-217Bisphosphonate osteonecrosis of the jaw – a literature review of UK policies versus international policies on bisphosphonates, risk factors and preventionhttp://www.nature.com/articles/sj.bdj.2011.744.pdf, http://www.nature.com/articles/sj.bdj.2011.744, http://www.nature.com/articles/sj.bdj.2011.744.pdf
10.21203/rs.3.rs-117921/v12020The Awareness and Perceptions of Dentists Regarding Medication-related Osteonecrosis of the Jaw and its Prevention: A Cross-sectional SurveyA lum Hanhttps://www.researchsquare.com/article/rs-117921/v1, https://www.researchsquare.com/article/rs-117921/v1.html
10.21203/rs.3.rs-117921/v22021The awareness and perceptions of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional surveyA lum Hanhttps://www.researchsquare.com/article/rs-117921/v2, https://www.researchsquare.com/article/rs-117921/v2.html
Dental Clinics of North America10.1016/j.cden.2013.12.0062014582369-384Antiresorptive Drug–Related Osteonecrosis of the JawJettie Uyanne, Colonya C. Calhoun, Anh D. Lehttps://api.elsevier.com/content/article/PII:S0011853213001353?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0011853213001353?httpAccept=text/plain
Journal of Evidence Based Dental Practice10.1016/j.jebdp.2017.03.0072017172105-106The Risk of Medication-Related Osteonecrosis of the Jaw After Dental Extraction is Higher for Patients on Intravenous as Compared With Oral Antiresorptive DrugsElliot Abthttps://api.elsevier.com/content/article/PII:S1532338217300830?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S1532338217300830?httpAccept=text/xml